日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

HLA Class II Alleles Are Associated With Anti-Drug Antibodies in Ulcerative Colitis Patients Treated With Etrolizumab

HLA II 类等位基因与接受依曲珠单抗治疗的溃疡性结肠炎患者体内的抗药抗体相关

Saha, Ashis; McCarthy, Mark I; Fischer, Saloumeh K; Sperinde, Gizette; Hammer, Christian

Adhesion strength of tumor cells predicts metastatic disease in vivo

肿瘤细胞的黏附强度可预测体内转移性疾病。

Madison A Kane ,Katherine G Birmingham ,Benjamin Yeoman ,Neal Patel ,Hayley Sperinde ,Thomas G Molley ,Pranjali Beri ,Jeremy Tuler ,Aditya Kumar ,Sarah Klein ,Somaye Zare ,Anne Wallace ,Parag Katira ,Adam J Engler

Population pharmacokinetic analysis of etrolizumab in patients with moderately-to-severely active ulcerative colitis

对中重度活动性溃疡性结肠炎患者进行etrolizumab群体药代动力学分析

Moein, Anita; Lu, Tong; Jönsson, Siv; Ribbing, Jakob; Kassir, Nastya; Zhang, Wenhui; Sperinde, Gizette; Zhang, Rong; Tang, Meina; Oh, Young S; Bruno, Rene; Zhu, Rui

Dose-dependent inactivation of airway tryptase with a novel dissociating anti-tryptase antibody (MTPS9579A) in healthy participants: A randomized trial

在健康受试者中,使用新型解离型抗类胰蛋白酶抗体 (MTPS9579A) 可剂量依赖性地灭活气道类胰蛋白酶:一项随机试验

Rymut, Sharon M; Sukumaran, Siddharth; Sperinde, Gizette; Bremer, Meire; Galanter, Joshua; Yoshida, Kenta; Smith, Jordan; Banerjee, Prajna; Sverkos, Viyia; Cai, Fang; Steffen, Verena; Henderson, Lindsay M; Rhee, Horace; Belloni, Paula N; Lin, Joseph H; Staton, Tracy L

Safety and Efficacy of T-DM1 Plus Neratinib in Patients With Metastatic HER2-Positive Breast Cancer: NSABP Foundation Trial FB-10

T-DM1联合奈拉替尼治疗转移性HER2阳性乳腺癌患者的安全性和有效性:NSABP基金会FB-10试验

Abraham, Jame; Montero, Albert J; Jankowitz, Rachel C; Salkeni, Mohamad Adham; Beumer, Jan H; Kiesel, Brian F; Piette, Fanny; Adamson, Laura M; Nagy, Rebecca J; Lanman, Richard B; Sperinde, Jeff; Huang, Weidong; Allegra, Carmen J; Srinivasan, Ashok; Wang, Ying; Pogue-Geile, Katherine L; Lucas, Peter C; Jacobs, Samuel A

An in vitro FcRn- dependent transcytosis assay as a screening tool for predictive assessment of nonspecific clearance of antibody therapeutics in humans

体外 FcRn 依赖性转胞吞试验作为预测评估人体抗体治疗非特异性清除率的筛选工具

Shan Chung, Van Nguyen, Yuwen Linda Lin, Julien Lafrance-Vanasse, Suzie J Scales, Kevin Lin, Rong Deng, Kathi Williams, Gizette Sperinde, Juan Jenny Li, Kai Zheng, Siddharth Sukumaran, Devin Tesar, James A Ernst, Saloumeh Fischer, Greg A Lazar, Saileta Prabhu, An Song

p95HER2-T cell bispecific antibody for breast cancer treatment

用于乳腺癌治疗的p95HER2-T细胞双特异性抗体

Irene Rius Ruiz ,Rocio Vicario ,Beatriz Morancho ,Cristina Bernadó Morales ,Enrique J Arenas ,Sylvia Herter ,Anne Freimoser-Grundschober ,Jitka Somandin ,Johannes Sam ,Oliver Ast ,Águeda Martinez Barriocanal ,Antonio Luque ,Marta Escorihuela ,Ismael Varela ,Isabel Cuartas ,Paolo Nuciforo ,Roberta Fasani ,Vicente Peg ,Isabel Rubio ,Javier Cortés ,Violeta Serra ,Santiago Escriva-de-Romani ,Jeff Sperinde ,Ahmed Chenna ,Weidong Huang ,John Winslow ,Joan Albanell ,Joan Seoane ,Maurizio Scaltriti ,Jose Baselga ,Josep Tabernero ,Pablo Umana ,Marina Bacac ,Cristina Saura ,Christian Klein ,Joaquín Arribas

High p95HER2/HER2 Ratio Associated With Poor Outcome in Trastuzumab-Treated HER2-Positive Metastatic Breast Cancer NCCTG N0337 and NCCTG 98-32-52 (Alliance)

p95HER2/HER2 比值高与曲妥珠单抗治疗的 HER2 阳性转移性乳腺癌预后不良相关 NCCTG N0337 和 NCCTG 98-32-52 (Alliance)

Chumsri, Saranya; Sperinde, Jeff; Liu, Heshan; Gligorov, Joseph; Spano, Jean-Philippe; Antoine, Martine; Moreno Aspitia, Alvaro; Tan, Winston; Winslow, John; Petropoulos, Christos J; Chenna, Ahmed; Bates, Michael; Weidler, Jodi Marie; Huang, Weidong; Dueck, Amylou; Perez, Edith A

Predictive value of quantitative HER2, HER3 and p95HER2 levels in HER2-positive advanced breast cancer patients treated with lapatinib following progression on trastuzumab

定量 HER2、HER3 和 p95HER2 水平对接受拉帕替尼治疗且曲妥珠单抗治疗后病情进展的 HER2 阳性晚期乳腺癌患者的预测价值

Duchnowska, Renata; Sperinde, Jeff; Czartoryska-Arłukowicz, Bogumiła; Myśliwiec, Paulina; Winslow, John; Radecka, Barbara; Petropoulos, Christos; Demlova, Regina; Orlikowska, Marlena; Kowalczyk, Anna; Lang, Istvan; Ziółkowska, Barbara; Dębska-Szmich, Sylwia; Merdalska, Monika; Grela-Wojewoda, Aleksandra; Żawrocki, Anton; Biernat, Wojciech; Huang, Weidong; Jassem, Jacek

A phase II study of ixabepilone and trastuzumab for metastatic HER2-positive breast cancer

一项针对转移性 HER2 阳性乳腺癌的 ixabepilone 和 trastuzumab 的 II 期研究

Tolaney, S M; Najita, J; Sperinde, J; Huang, W; Chen, W Y; Savoie, J; Fornier, M; Winer, E P; Bunnell, C; Krop, I E